198.00
-2.00
(-1.00%)
At close: January 31 at 5:32:30 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 6 | 11 | 10 |
| Avg. Estimate | 10.06B | 10.18B | 41.16B | 43.28B |
| Low Estimate | 9.96B | 10.05B | 39.23B | 40.92B |
| High Estimate | 10.17B | 10.46B | 42.42B | 46.27B |
| Year Ago Sales | 9.4B | 9.51B | 39.11B | 41.16B |
| Sales Growth (year/est) | 6.96% | 7.06% | 5.24% | 5.15% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| COFI.VI | -- | -- | -- | -- |
| S&P 500 | 10.32% | 10.05% | 13.98% | 13.74% |
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 1/27/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 1/22/2025 |
| Maintains | Barclays: Overweight to Overweight | 1/22/2025 |
| Upgrade | UBS: Neutral to Buy | 1/13/2025 |
| Initiated | Truist Securities: Buy | 1/7/2025 |
| Upgrade | Barclays: Equal-Weight to Overweight | 1/6/2025 |